Radiodermatitis, also commonly referred to as radiation dermatitis in medical terminology, is a symptom caused as result of using radiation therapy used to treat cancer as well as exposure to radiation during nuclear disasters. While treating cancer with radiotherapy, cumulative daily doses of radiation are given to the treatment field or target site on the body prevent normal skin to repopulate and weakens the skin integrity at and around the radiation field. Degree of radiodermatitis may be acute or chronic and encompasses localized erythema, skin shedding (desquamation), hair loss (epilation), fibrosis, necrosis, and other similar conditions. According to the WHO, the number of new patients of cancer is expected to grow by 70% in the next two decades. The growing number of cancer patients around the world is the chief driving force behind the radiodermititis market’s growth however higher cost and adequate infrastructure in the major parts of the world is expected to be key restraining factor for the radiodermititis market.
Geographically Asia-Pacific dominated radiodermititis market driven by best in the developing healthcare infrastructure, increasing awareness, increasing cancer patients and growing spending by the citizens towards healthcare expenditure. Asia-Pacific was followed by Europe and North America as second and third largest market for radiodermititis market. Asia Pacific is projected to have fastest growth, owing to rapidly increasing healthcare infrastructure, increased spending, government initiatives and increasing awareness amongst population, and growing medical tourism industry in developing nations such as China, and India in this region.
This report identifies the global radiodermititis market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global radiodermititis market.
This report segments radiodermititis market on the basis of product type, distribution channel type and regional market as follows:
- Radiodermititis Market, By Product Type: Topical, Oral Medication, Dressings and others
- Radiodermititis Market, By Distribution channel: Hospital Pharmacy, Retail Pharmacy Store, Online Store and others
- This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
This report identifies all the major companies operating in the radiodermititis market. Some of the major companies’ profiles in detail are as follows:
- 3M Health Care
- BMG Pharma
- Molnlycke Health Care
- Smith & Nephew plc
- Derma Sciences, Inc.